Acute Radiation Syndrome Clinical Trial
Official title:
A Phase I Study to Evaluate the Safety and Pharmacokinetics of RadProtect® in Healthy Volunteers
This is a Phase 1, non-randomized, sequential-cohort, dose escalation, open-label study designed to evaluate the safety and tolerability of RadProtect® in healthy volunteers. This study is to be conducted at two clinical centers and in conformity with Good Clinical Practice (GCP).
n/a
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00504335 -
Safety and Pharmacokinetic Study of BIO 300 Capsules
|
Phase 1 | |
| Completed |
NCT03585803 -
A Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of KMRC011
|
Phase 1 | |
| Completed |
NCT04650555 -
BIO 300 Oral Powder Safety and Pharmacokinetics
|
Phase 1 | |
| Active, not recruiting |
NCT00903929 -
Phase I Study of Eltrombopag for Promoting Thrombopoiesis After Total Body Irradiation
|
Phase 1 |